Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02ULG
|
|||
| Former ID |
DIB010096
|
|||
| Drug Name |
CP-4033
|
|||
| Synonyms |
Ribavirin derivative (lipid vector technology, thyroid cancer), Clavis Pharma; Ribavirin derivative (lipid vector technology, thyroid cancer), Translational Therapeutics
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Investigative | [1] | |
| Company |
Clavis Pharma AS
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.